Nuvation Bio Inc.
Diarylhydantoin compounds and methods of use thereof
Last updated:
Abstract:
The disclosure relates to anti-cancer compounds derived from nuclear steroid receptor binders, to products containing the same, as well as to methods of their use and preparation.
Status:
Grant
Type:
Utility
Filling date:
27 Nov 2019
Issue date:
5 Apr 2022